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Outcome of 1051 Octogenarian Patients With ST-Segment Elevation
Myocardial Infarction Treated With Primary Percutaneous Coronary
Intervention: Observational Cohort From the London Heart Attack
Group
Daniel I. Bromage, MD; Daniel A. Jones, MD; Krishnaraj S. Rathod, MD; Claire Grout, MD; M. Bilal Iqbal, MD; Pitt Lim, MD; Ajay Jain, MD;
Sundeep S. Kalra, MD; Tom Crake, MD; Zoe Astroulakis, MD; Mick Ozkor, MD; Roby D. Rakhit, MD; Charles J. Knight, MD; Miles C. Dalby,
MD; Iqbal S. Malik, MD; Anthony Mathur, MD; Simon Redwood, MD; Philip A. MacCarthy, MD; Andrew Wragg, MD
Background-—ST-segment elevation myocardial infarction is increasingly common in octogenarians, and optimal management in
this cohort is uncertain. This study aimed to describe the outcomes of octogenarians with ST-segment elevation myocardial
infarction treated by primary percutaneous coronary intervention.
Methods and Results-—We analyzed 10 249 consecutive patients with ST-segment elevation myocardial infarction treated with
primary percutaneous coronary intervention between 2005 and 2011 at 8 tertiary cardiac centers across London, United
Kingdom. The primary end point was all-cause mortality at a median follow-up of 3 years. In total, 1051 patients (10.3%) were
octogenarians, with an average age of 84.2 years, and the proportion increased over the study period (P=0.04). In-hospital
mortality (7.7% vs 2.4%, P<0.0001) and long-term mortality (51.6% vs 12.8%, P<0.0001) were increased in octogenarians
compared with patients aged <80 years, and age was an independent predictor of mortality in a fully adjusted model (hazard
ratio 1.07, 95% CI 1.07–1.09, P<0.0001). Time-stratiﬁed analysis revealed an increasingly elderly and more complex cohort
over time. Nonetheless, long-term mortality rates among octogenarians remained static over time, and this may be
attributable to improved percutaneous coronary intervention techniques, including signiﬁcantly higher rates of radial access
and lower bleeding complications. Variables associated with bleeding complications were similar between octogenarian and
younger cohorts.
Conclusions-—In this large registry, octogenarians undergoing primary percutaneous coronary intervention had a higher rate of
complications and mortality compared with a younger population. Over time, octogenarians undergoing primary percutaneous
coronary intervention increased in number, age, and complexity. Nevertheless, in-hospital outcomes were reasonable, and long-
term mortality rates were static. ( J Am Heart Assoc. 2016;5:e003027 doi: 10.1161/JAHA.115.003027)
Key Words: acute myocardial infarction • aging • cardiovascular disease • complications • elderly • epidemiology
• octogenarian • outcome • primary percutaneous coronary intervention
W estern populations are gradually aging. Between 1985and 2010, the number of people aged >80 years in
the developed world has more than doubled to 53 million, and
this trend is predicted to continue.1 Coronary artery disease is
common in elderly patients: An estimated 13% of ST-segment
elevation myocardial infarction (STEMI) in Western cohorts
occurs in patients aged >80 years.2 Consequently, as the
population ages, we can expect to see more elderly patients
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presenting with STEMI. Furthermore, STEMI in elderly patients
is associated with high mortality, estimated to be up to 47% at
1 year, which is unsurprising, given that comorbidities
increase with age.3–8
Primary percutaneous coronary intervention (PPCI) has
been shown to be beneﬁcial in younger patients with STEMI
and is increasingly being used in octogenarians.9 PPCI in
octogenarians is associated with improved survival compared
with medical therapy alone, albeit often in subgroup analy-
ses;10–15 however, advanced age has been associated with
worse outcomes after PPCI compared with younger patients
in several recent cohort studies.2,16–19 Moreover, there is a
paucity of evidence on the optimal management of STEMI in
octogenarians as a result of their underrepresentation in
clinical trials, the perceived increased risks related to
comorbidities, and the presumed limited scope for symp-
tomatic improvement. Nonetheless, there is no upper age
limit for offering PPCI in current guidelines.20,21
In this large cohort of elderly patients, we aimed to
describe the population and their short- and long-term
outcomes after PPCI for STEMI. We also compared the
clinical outcomes with a younger group of patients, examined
changes over time, and investigated any associations
between outcome and procedural characteristics.
Methods
This retrospective observational cohort study investigated the
characteristics and outcomes of octogenarians after PPCI for
STEMI compared with nonoctogenarian patients. We merged
the databases of the 8 heart attack centers in London, United
Kingdom, that collect data based on the British Cardiac
Intervention Society (BCIS) data set. The BCIS audit is part of
a national mandatory audit in which all UK PCI centers
participate.
BCIS–National Institute for Cardiovascular
Outcomes Research Database
The UK BCIS audit collects data from all hospitals in the United
Kingdom that perform PCI and records information about every
procedure performed.22 PCI is deﬁned as the use of any
coronary device to approach, probe, or cross ≥1 coronary
lesion, with the intention of performing a coronary intervention.
The database is part of the suite of data sets collected under the
auspices of the National Institute for Cardiovascular Outcomes
Research and is compliant with UK data protection legislation.
Data are collected prospectively at each hospital, encrypted
electronically, and transferred online to a central database.
Each patient entry offers details of the patient journey, including
the method and timing of admission, inpatient investigations,
results, treatment, and outcomes. Patient survival data are
obtained by linkage of patient National Health Service (NHS)
numbers to the Ofﬁce of National Statistics, which records live
status and the date of death for all deceased patients.
Population Study and Design
We examined an observational cohort of consecutive
patients with STEMI treated with PPCI between January
2005 and July 2011 at all 8 tertiary cardiac centers in
London. Patient and procedural details were recorded at the
time of the procedure and during the admission into each
center’s local BCIS database. Anonymous data sets with
linked mortality data from the Ofﬁce of National Statistics
from the 8 centers were merged for analysis. During the
study period, 11 466 patients underwent PPCI. Of these,
10 249 (88%) had complete data sets and NHS numbers and
were included in the analysis. The octogenarian subgroup
included all patients aged ≥80 years at the time of PPCI, and
patients did not switch groups if they passed age 80 years
during the follow-up period.
Clinical Outcomes
Patient clinical and demographic data, procedural character-
istics, bleeding complications, procedural complications, and
major adverse cardiac events, including all-cause in-hospital
mortality, nonfatal myocardial infarction (MI), reintervention,
and stroke, were recorded during admission. Bleeding was
deﬁned as access-site bleeding, gastrointestinal bleeding,
intrapericardial bleeding with tamponade, or requirement for
blood transfusion. Access-site bleeding was deﬁned as
bleeding delaying discharge, large hematomas (deﬁned as
a hematoma that results in a change in management,
including delay of discharge), retroperitoneal bleeding, and
pseudoaneurysm formation. Major bleeding was deﬁned as
per bleeding, but only hematomas requiring blood transfu-
sion were included. In-hospital major adverse cardiac events
were deﬁned as death, MI (new pathological Q waves in the
distribution of the treated coronary artery with an increase
of creatine kinase-MB to ≥2 times the reference value or
signiﬁcant rise in troponin T values), stroke, and target
vessel revascularization. Procedural complications recorded
included MI, emergency coronary artery bypass grafting,
arterial complications, aortic or coronary dissection, side
branch occlusion, and arrhythmia. Following discharge, long-
term all-cause mortality was obtained by linkage to the
Ofﬁce of National Statistics (England and Wales). A
successful PPCI result was deﬁned as ﬁnal TIMI (Thrombol-
ysis In Myocardial Infarction) ﬂow grade 3 and residual
stenosis <20% in the infarct-related artery at the end of the
procedure.
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Ethics
The data were collected as part of a national cardiac audit,
and all patient-identiﬁable ﬁelds were removed prior to
analysis. The local ethics committee advised us that formal
ethics approval was not required.
Statistical Methods
Clinical characteristics of octogenarians versus younger
patients were compared using the Pearson chi-square test
for categorical variables and the Student t test for continuous
variables. Normality of distribution was assessed using the
Shapiro-Wilks test. We calculated Kaplan–Meier product limits
for cumulative probability of reaching an end point and used
the log-rank test for evidence of a statistically signiﬁcant
difference between the groups. Time was measured from the
ﬁrst admission for a procedure to outcome (all-cause
mortality). Cox regression analysis was used to estimate
hazard ratios (HRs) for the effect of age in fully adjusted
models, based on covariates (P<0.05) associated with the
outcome. The proportional hazards assumption was evaluated
by examining log (-log) survival curves and tested with
Schoenﬁeld residuals and was satisﬁed for all outcomes
evaluated. To determine independent predictors of other
clinical and composite outcomes, a logistic regression model
adjusting for 24 patient, clinical, and procedural variables was
used to provide adjusted odds ratios (ORs) with associated
95% CIs. A P value <0.05 was considered signiﬁcant. We used
SPSS for Mac version 19.0 (IBM Corp) for all analyses.
Results
Patient Characteristics
A total of 1051 octogenarians (10.3% of the study population)
with an average age of 84.2 years were treated with PPCI
during the study period. Over time, the annual number of
octogenarians gradually increased from 47 (9.1%) in 2005 to
103 (10.5%) in 2011 (P=0.04). The age distribution of the
study cohort is shown in Figure 1.
Compared with patients aged <80 years, octogenarian
STEMI patients included a higher proportion of women and
had a higher prevalence of hypertension, hypercholes-
terolemia, previous stroke, peripheral vascular disease,
chronic renal failure, and previous coronary artery bypass
grafting. They were also more likely to have worse left
ventricular systolic function and to present with cardiogenic
shock. The groups aged <80 years were more likely to have a
smoking history and to have had previous PCI. The octoge-
narian group had longer call-to-balloon times but similar door-
to-balloon times. Baseline characteristics are given in Table 1.
Procedural characteristics
Octogenarian patients were more likely to have multivessel
disease and less likely to undergo radial access or to receive
adjunctive therapies such as glycoprotein (GP) IIb/IIIa
inhibitors and thrombectomy. There were lower rates of stent
placement in the octogenarian group, and when stents were
inserted, they were less likely to be drug-eluting stents
(DESs). The procedure was more likely to be successful in
younger patients. Procedural characteristics are given in
Table 2.
Procedural and In-Hospital Complications
The rate of complications was higher in patients aged >80
years, including signiﬁcantly more bleeding complications and
subsequent blood transfusion. Consequently, the group aged
>80 years had signiﬁcantly longer in-patient stays. In-hospital
major adverse cardiac event rates were signiﬁcantly higher in
the octogenarian group compared with the younger group,
accounted for by signiﬁcantly increased all-cause mortality
(7.7% vs 2.4%, P<0.0001) and Q wave MI (3.0% vs 1.7%,
P=0.006). Procedural and in-hospital complications are shown
in Table 3.
Long-Term All-Cause Mortality
Kaplan–Meier analysis showed that the cumulative incidence
of all-cause mortality during follow-up was signiﬁcantly higher
in the octogenarian group compared with the younger
subgroup (median follow-up 3.0 years [interquartile range
1.2–4.6 years]; 51.6% vs 12.8%, P<0.0001) (Figure 2). The
Figure 1. Age distribution of patients aged >80 years. The bar
graph shows the absolute numbers of patients undergoing
primary percutaneous coronary intervention between 2005 and
2011 according to age.
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hazard of death during follow-up increased with age (unad-
justed HR 1.07 per year increase, 95% CI 1.06–1.08,
P<0.0001) and persisted after adjustment for other predictors
of mortality (HR 1.07, 95% CI 1.07–1.09, P<0.0001) (Fig-
ure 3). After adjustment for confounding variables, other
independent predictors of increased long-term all-cause
Table 1. Baseline Patient Characteristics According to Age
<80 Years
(n=9198)
>80 Years
(n=1051) P Value
Complete
Data, %
Sex (female) 1800 (19.6) 474 (45.4) <0.0001 99.8
Hypertension 3692 (42.3) 501 (51.3) 0.02 95.1
Diabetes mellitus 1398 (16.1) 137 (13.9) 0.073 94.4
Hypercholesterolemia 3708 (42.5) 548 (56.1) <0.0001 95.1
Smoking history 5611 (61) 379 (36.1) <0.0001 87.4
Previous MI 1442 (16.9) 182 (18.7) 0.150 92.2
Previous CABG 264 (3.0) 46 (4.6) 0.01 96.3
PVD 145 (1.7) 29 (3.0) 0.007 95.1
Previous stroke 155 (1.8) 45 (4.6) <0.0001 95.1
Cardiogenic shock 517 (5.7) 82 (7.9) 0.004 98.5
Previous PCI 1078 (12.3) 87 (8.7) 0.001 95.6
CRF 72 (0.9) 16 (1.8) 0.017 89.7
Poor LV (<30%) 572 (15.1) 80 (20.6) 0.007 40.0
Ethnicity (white) 1081 (67.6) 697 (61.8) 0.32 91.2
Data expressed as number (%) or median (interquartile range). CABG indicates coronary artery bypass grafting; CRF, chronic renal failure; LV, left ventricle; MI, myocardial infarction; PCI,
percutaneous coronary intervention; PVD, peripheral vascular disease.
Table 2. Procedural Characteristics According to Age
<80 Years
(n=9198)
>80 Years
(n=1051) P Value
Complete
Data, %
Radial access 2115 (23.4) 194 (18.8) 0.001 98.3
Multivessel disease 3821 (41.8) 562 (54) <0.0001 94.6
Multivessel intervention 917 (10) 277 (26) 0.002 98.9
Target vessel in single-vessel intervention 98.9
Right coronary artery 3352 (42.3) 392 (45.5) 0.076
Left main coronary artery 44 (0.60) 12 (1.4) 0.010
Left anterior descending 3458 (43.6) 360 (41.8) 0.294
Left circumflex 1071 (13.5) 98 (11.4) 0.081
Stent placed 8432 (91.7) 938 (89.2) 0.014 96.0
Drug-eluting stent use 4058 (45.9) 311 (30.9) <0.0001 96.0
Average number of stents used 1.4 (1.13) 1.5 (0.96) 0.569 98.4
Glycoprotein IIb/IIIa inhibitor use 6843 (74.4) 530 (50.4) <0.0001 95.5
Thrombectomy device use 3458 (37.6) 283 (27) <0.0001 95.5
Procedural success 6932 (88.3) 890(84.7) 0.003 84.8
Call to balloon time (min) 130 (82–171) 168 (120–220) 0.018 61.0
Door to balloon time (min) 43 (25–128) 45 (28–134) 0.562 61.0
Data expressed as number (%) or median (interquartile range).
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mortality were cardiogenic shock, poor left ventricular
function, chronic renal failure, multivessel disease, femoral
access, bare metal stent use, and procedural failure.
Bleeding Complications
Overall bleeding rates were greater in the octogenarian group
(3.43% vs 1.00%, P=0.002%) and was driven by access-site
bleeding (1.93% vs 0.28%, P=0.002) and necessitated greater
volume of blood transfusions (0.76% vs 0.30%, P=0.026).
When corrected for baseline clinical and procedural variables
(24-variable model), multivariate analysis identiﬁed the fol-
lowing variables as independent predictors of bleeding: age
(OR 1.25, 95% CI 1.10–1.42, P<0.0001); peripheral vascular
disease (OR 3.69, 95% CI 1.20–11.37, P=0.023); female sex
(OR 1.85, 95% CI 1.39–4.02, P<0.001); GP IIb/IIIa inhibitor
use (OR 2.10, 95% CI 1.33–3.03, P=0.010); intra-aortic
balloon pump use (OR 5.45, 95% CI 1.53–15.27, P=0.008);
and previous stroke (OR 3.49, 95% CI 1.25–8.93, P=0.009)
with radial access (OR 0.20, 95% CI 0.10–0.77, P=0.002), a
predictor of reduced bleeding events. Multivariate Cox
analysis revealed bleeding complications to be an indepen-
dent predictor of mortality (HR 2.34, 95% CI 1.34–3.56,
P=0.002). When separated into young and octogenarian
groups, no differences were seen in variables associated with
bleeding complications, which matched the overall cohort
(female sex, radial access, GP IIb/IIIa inhibitor use, previous
stroke, peripheral vascular disease, and intra-aortic balloon
pump use).
Octogenarian Subgroup Analysis
In the octogenarian subgroup, similar univariate predictors of
mortality were present, including shock, access route, and
nonuse of DESs, GP IIb/IIIa, and thrombectomy (data not
Table 3. Procedural and In-Hospital Complications
<80 Years
(n=9198)
>80 Years
(n=1051) P Value Complete Data, %
Procedural complications 96.5
Total 444 (4.8) 98 (9.3) <0.0001
Coronary dissection 59 (0.6) 6 (0.6) 1.000
Aortic dissection 3 (0.03) 0 (0.0) 1.000
Coronary perforation 14 (0.2) 5 (0.5) 0.034
Heart block 43 (0.5) 15 (1.7) <0.0001
No/slow flow 128 (1.4) 16 (1.8) 0.576
Bleeding complications 87 (1.0) 36 (3.43) 0.002
Blood Transfusion 28 (0.3) 8 (0.76) 0.026
MACE 460 (5.0) 120 (11.4) <0.0001 96.5
Mortality 211 (2.4) 78 (7.7) <0.0001
Q wave MI 149 (1.7) 30 (3.0) 0.006
Non–Q Wave MI 26 (0.37) 3 (0.3) 1.000
Emergency CABG 30 (0.3) 5 (0.5) 0.399
Reintervention PCI 44 (0.48) 4 (0.38) 0.814
Stroke 17 (0.2) 7 (0.67) 0.008
Data expressed as number (%). CABG indicates coronary artery bypass grafting; MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention.
Figure 2. Kaplan–Meier curves showing all-cause mortality
after PPCI. Kaplan–Meier curves showing the cumulative proba-
bility of all-cause mortality after PPCI according to group. LR
indicates log-rank; PPCI, percutaneous coronary intervention.
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shown). After correction for sex and comorbidities including
diabetes, previous MI, previous revascularization (coronary
artery bypass grafting, PCI), hypertension, hypercholes-
terolemia, peripheral vascular disease, stroke, chronic renal
failure, poor left ventricular function, GP IIb/IIIa use, proce-
dural success, DES use, thrombectomy use, shock, access
and multivessel disease, multivariate analysis of the octoge-
narian subgroup corroborated the ﬁnding in the whole study
population that cardiogenic shock, femoral access, chronic
renal failure, and poor left ventricular and procedural failure
were independent predictors of mortality (Figure 4). In parallel
to the young group, GP IIb/IIIa use (HR 0.49, 95% CI 0.28–
0.85), radial access (HR 0.58, 95% CI 0.29–0.98) and DES use
(HR 0.60, 95% CI 0.32–0.98) were all signiﬁcantly associated
with improved survival (Figure 4).
Octogenarian Time-Stratiﬁed Analysis
Further Kaplan–Meier analysis according to time period
among the octogenarian group demonstrated that the
difference in cumulative incidence of all-cause long-term
mortality during follow-up was not signiﬁcantly different
between the 2005–2008 and 2008–2011 time periods
(33.8% vs 29.7%, P=0.89). In addition, between 2008 and
2011, octogenarian patients were signiﬁcantly older. They
were also more complicated, with higher rates of diabetes
mellitus, previous MI, and revascularization, and signiﬁcantly
more likely to present with cardiogenic shock. Their proce-
dural characteristics revealed a higher likelihood of radial
access and DES use and a smaller chance of receiving either
thrombectomy or a GP IIb/IIIa inhibitor (Table 4). There were
higher rates of procedural success (86.4% vs 83.8%, P=0.031)
and lower rates of bleeding complications (1.9% vs 5.4%,
P=0.028).
Discussion
There is increasing interest in the management of octoge-
narian patients presenting with STEMI. This study sought to
describe a population of octogenarians and their outcomes
Figure 3. Multivariate Cox regression analysis for hazard of all-cause mortality after PPCI. multivariate Cox regression analysis for hazard of
all-cause mortality after PPCI. CABG indicates coronary artery bypass grafting; CKD, chronic kidney disease; GP, glycoprotein; MI, myocardial
infarction; PPCI, primary percutaneous coronary intervention; TIMI, Thrombolysis In Myocardial Infarction.
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after PPCI for STEMI and to compare both short- and long-
term clinical outcomes with younger patients. As suspected,
we found an association between octogenarian patients and
increased procedural complications, in-hospital major adverse
cardiac events, and long-term all-cause mortality, which
conﬁrms the ﬁndings of several recent studies.2,7,19,23
Similarly, our study conﬁrms that the annual proportion and
absolute numbers of octogenarians gradually increased over
the study period, making this an increasingly important
patient group.7,8 Our data, from one of the largest registries of
PPCI cases in octogenarians collected over 7 years, demon-
strate that the proportion of PPCI procedures for octogenar-
ians increased annually to 10.5% in 2011, reﬂecting
increasing numbers and experience of PPCI for octogenarians
with STEMI.
In addition to these ﬁndings, we made several interesting
observations. First, despite an increase in the mean age and
the complexity of octogenarian patients undergoing PPCI,
including more diabetes mellitus, previous MI and revascular-
ization, and greater likelihood of presenting with cardiogenic
shock, long-term all-cause mortality remained the same over
time. This may be attributable to an improved PPCI technique
in view of our ﬁndings of increased radial access, improved
procedural success rates, and lower bleeding rates, although
we are unable to comment on causality. This is consistent
with the ﬁnding of Di Bari and colleagues that the application
of PCI for acute coronary syndrome is associated with greater
long-term survival in patients aged >75 years with higher
background risk, despite being applied less frequently in
higher risk patients.15 In this regard, we hypothesize that the
deleterious increasing age of the octogenarian cohort is offset
by improved outcomes in higher risk patients, resulting in
overall static long-term all-cause mortality. This may be a
result of the observed increased application of evidence-
based interventions, including radial access and DESs, both of
which may contribute to our ﬁnding of increased procedural
success in more complex patients with STEMI over time.
Second, in-hospital mortality of 7.7% for this octogenarian
cohort versus 2.4% for younger patients was both reasonable
and comparable to recently published studies in similar
cohorts.2,19 Nevertheless, our data are typical in demonstrat-
ing higher rates of cardiovascular risk factors, vascular
disease in other distributions, worse left ventricular systolic
function, and more cardiogenic shock, which is a particularly
stronger predictor of mortality in elderly compared with
younger patients, both in this study and others.19,24,25
Consequently, octogenarian patients undergoing PPCI for
STEMI in this cohort had signiﬁcantly higher 3-year mortality
Figure 4. Multivariate Cox regression analysis for hazard of all-cause mortality after PPCI in octogenarians. Multivariate Cox regression
analysis for hazard of all-cause mortality after PPCI. CABG indicates coronary artery bypass grafting; CKD, chronic kidney disease; GP,
glycoprotein; MI, myocardial infarction; PPCI, primary percutaneous coronary intervention; TIMI, Thrombolysis In Myocardial Infarction.
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than patients aged <80 years (51.6% vs 12.8%). This is similar
to the limited number of studies to date that have examined
long-term outcomes after PPCI in octogenarians. Kvakkestad
and colleagues, for example, found 58% 3-year survival among
octogenarians undergoing intervention for STEMI.7,8,19
Reasons for worse outcome after PPCI in elderly patients
are likely to be multifactorial, including increased comorbidi-
ties, longer call-to-balloon times resulting in larger infarcts,
reduced cardiovascular reserve, increased acute MI sequelae
and more iatrogenic complications.3 Nearly all studies have
shown, for example, increased access-related complications,
including bleeding events, in elderly patients6,26 as well as
higher risk of in-hospital stroke.17,27 Elderly patients are also
more susceptible to contrast-induced nephropathy after PCI
on account of more complex lesions that may mandate
increased contrast use28 and worse preexisting renal func-
tion.29
Third, the use of radial access, DES, GP IIb/IIIa inhibitors,
and thrombectomy catheters was signiﬁcantly less in the
elderly cohort compared with the younger group, although
both GP IIb/IIIa and thrombectomy use decreased over the
study period in the whole cohort; this decrease may be
explained by the publication of new trial data.30 Comorbidities
may account for this disparity, including, for example,
increased anemia, bleeding diatheses, and vascular disease;
however, it is also possible that such interventions are
underused in elderly patients because of concerns about
increased risk and lack of available evidence. Although the
evidence for thrombectomy and GP IIb/IIIa inhibition in STEMI
is mixed,30–36 most studies investigating these interventions,
as well as radial access and DES use, have excluded very
elderly populations. After multivariate analysis of mortality
following PPCI in the octogenarian cohort, the present study
showed that, despite lower use of these therapies, radial
access, GP IIb/IIIa inhibition, and DES use were associated
with improved all-cause mortality.
Only a small number of studies have examined the impact
of procedural factors on outcome in elderly patients. A small
observational study comparing octogenarian and younger
patients receiving DESs for acute MI, unsurprisingly, found
more cardiac death in the octogenarian cohort37; however,
none of this excess mortality was due to stent thrombosis.
Others have described a decline in DES use for all PCI in
elderly patients, which interestingly did not appear to affect
overall mortality, bleeding, or revascularization.38 Regarding
access route, a study comparing radial and femoral access in
octogenarians undergoing primary or rescue PCI demon-
strated signiﬁcantly higher bleeding complications in the
femoral group and a higher conversion rate in the radial group,
implying that radial access is feasible and safe in this
cohort.39 Radial access may be preferable in elderly patients
because they have signiﬁcantly higher baseline risk of arterial
access complications.40 It also facilitates early ambulation,
which is particularly important for these patients who are at
increased risk of venous thromboembolism and hospital-
acquired infections. Our observation that radial access is
associated with improved outcome among octogenarians
undergoing PPCI for STEMI may be confounded by case
selection (whereby patients at highest risk preferentially
receive femoral access); however, we previously described
that patients with high baseline risk may, in fact, beneﬁt most
from radial access.41
Fourth, our study conﬁrms that bleeding is an independent
predictor of mortality in octogenarian and younger cohorts,
Table 4. Time-Stratiﬁed Analysis Among Patients Aged
>80 Years Comparing 2005–2008 With 2008–2011
2005–2008
(n=442)
2009–2011
(n=609) P Value
Patient characteristics
Age, y 83.863.16 84.483.83 <0.0001
Sex (female) 194 (43.9) 280 (46.0) 0.571
Ethnicity (white) 296 (67.1) 401 (65.8) 0.435
Cardiogenic shock 22 (5.0) 60 (9.9) 0.005
Previous MI 81 (18.3) 101 (16.6) 0.358
Previous CABG 12(2.7) 34(5.4) 0.025
Previous PCI 27 (6.1) 60 (9.9) 0.048
Smoking history 162 (36.7) 217 (35.6) 0.078
Diabetes mellitus 52 (11.8) 85 (14.0) 0.039
Stroke 21 (4.8) 24 (3.9) 0.395
Peripheral
vascular disease
10 (2.3) 19 (3.1) 0.498
Procedural characteristics
GP IIb/IIIa inhibitor
use
255 (57.7) 275 (45.2) 0.005
Radial access 50 (11.3) 144 (23.6) <0.0001
Stent placed 358 (81.1) 580 (95.2) <0.0001
DES use 90 (20.4) 220 (36.1) <0.0001
Average number
of DESs used
0.350.76 0.610.96 <0.0001
Procedural success 370 (83.8) 520 (86.4) 0.031
Thrombectomy
device use
138 (31.2) 145 (23.8) 0.032
Total bleeding
complications
24 (5.4) 12 (1.9) 0.028
Major bleeding 12 (2.7) 7 (1.1) 0.082
Arterial complications 8 (1.8) 3 (0.5) 0.064
Blood transfusions 4 (0.9) 2 (0.3) 0.128
Data expressed as number (%) or mean (SD). CABG indicates coronary artery bypass
grafting; DES, drug-eluting stent; GP, glycoprotein; MI, myocardial infarction; PCI,
percutaneous coronary intervention.
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which has been demonstrated in numerous randomized and
observational studies.42 This result has been attributed to the
discontinuation of antithrombotic medication, hypoperfusion,
anemia, platelet activation, and/or the adverse effects of
transfusion.42 Furthermore, we found that age is an indepen-
dent predictor of bleeding.43–45 Interestingly, variables that
were independently associated with bleeding complications
were alike in both octogenarian and younger cohorts.
Finally, the present study identiﬁed longer call-to-balloon
times despite similar door-to-balloon times and a lower rate
of interhospital transfer among elderly patients. It is
recognized that elderly patients often do not undergo PPCI
for reasons including atypical or “silent” presentation,
increased prevalence of left bundle-branch block or residual
ST-segment elevation from old infarcts, reduced reporting of
chest pain, and increased incidence of heart failure on
presentation.3,46 Furthermore, confusion may be the pre-
senting feature in up to 20% of patients aged >85 years with
acute MI, complicating diagnosis and management.3 The
greater number of female octogenarians may exacerbate
these trends.47 Our data may reﬂect reluctance to transfer
elderly patients to tertiary units for PPCI for these reasons
and possible concerns about care needs and quality of life or
uncertainty or misconceptions about optimal care for the
elderly.
Strengths and Limitations of This Study
The strength of this study is that it includes patients from 8
different centers in a large metropolitan city with a diverse
ethnic and social makeup. Our cohort includes large numbers
of patients who either were brought directly to a PPCI center
or, alternatively, were transferred after assessment in a non–
PCI-capable hospital. The study included patients with
cardiogenic shock, previous bypass surgery, and other
comorbidities and thus is representative of the broad variety
of patients encountered in day-to-day clinical practice.
Although inclusion of such patients may result in selection
bias, the baseline characteristics were similar, and any
differences were adjusted for in the multivariate analyses.
Mortality tracking in England is particularly robust based on
ofﬁcial UK Ofﬁce of National Statistics data, and thus our
mortality end point is reliable. The multivariate analyses
highlight the quality of the data with well-recognized
predictors of mortality associated with adverse outcome in
our data set.
Nevertheless, our study has limitations. First, our study
applies only to patients with STEMI who received PPCI and not
to octogenarians undergoing PCI for other indications. In
addition, this study has all of the limitations of a registry and
all of the potential bias and residual confounding associated
with nonrandomized studies; therefore, the observed effect
may be caused by unrecorded variables. We were not able to
adjust for missing variables and those not collected by the
database. In addition, we cannot exclude the possibility of
underreporting of complications, although the tracking of
mortality is robust, and we included only the 88% of patients
who had deﬁnitive mortality data in our study cohort. It is
possible that some patients in the elderly group died prior to
getting to the PCI center, and that could have counterbal-
anced the longer treatment times. Finally, although only a
patient’s ﬁrst STEMI was included, repeat events at a different
institution could not be identiﬁed after electronic encryption
and merging of data sets from each institution; however, the
numbers are likely to be small, and this should not have
affected the primary mortality end point.
Conclusions
In this large registry, octogenarians undergoing PPCI had a
higher rate of complications and mortality compared with a
younger population. Over time, octogenarians undergoing
PPCI increased in number, age, and complexity. Nevertheless,
mortality rates were static, which may be attributable to
improved PPCI techniques, although further, randomized
studies are necessary. Despite the advanced age of the study
population, we suggest that the favorable short-term out-
comes described—in the absence of chronic kidney disease,
left ventricular failure, and cardiogenic shock—justify consid-
eration of PPCI for octogenarians with STEMI.
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